Finally, neither CLDN4 nor CLDN7 expression was significantly associated with survival of patients with TNBC, which contradicts the previously reported association between CLDN4 expression and BC tumor recurrence [29], [36]. The gene discussed is CLDN7; the disease is breast cancer.